U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 5
Annual Statement of Changes in Beneficial Ownership
Filed pursuant to Section 16(a) of the Securities Exchange Act of
1934, Section 17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
___ Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instructions 1(b).
___ Form 3 Holdings Reported
___ Form 4 Transactions Reported
1. Name and Address of Reporting Person
Patrick Waddy
C/o Dominion Biologicals
5 Isnor Drive
Dartmouth, NS B3B 1M1 Canada
2. Issuer Name and Ticker or Trading Symbol
Immucor, Inc./BLUD
3. IRS or Social Security Number of Reporting Person (Voluntary)
NA
4. Statement for Month/Year
5/99
5. If Amendment, Date of Original (Month/Year)
NA
6. Relationship of Reporting Person to Issuer (check all applicable)
Director
X Officer (give title below)
10% Owner
Other (specify below)
President of Dominion Biologicals and European Finance Director
<PAGE>
TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.3)
Common Stock, $.10 par value
2. Transaction Date (Month/Day/Year)
October 14, 1998
3. Transaction Code (Instr. 8)
P
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
Amount (A) or (D) Price
5,000 A $8.3125
5. Amount of Securities
Beneficially Owned at
End of Issuer's Fiscal
Year (Instr. 3 and 4)
5,000
15,000 (previously reported)
------
20,000
6. Ownership Form: 7. Nature of Indirect
Direct (D) or Indirect (I) Beneficial Ownership
(Instr. 4) (Instr. 4)
D NA
D NA
--- ----
D NA
TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially
Owned (e.g., puts, calls, warrants, options, convertible
securities)
1. Title of Derivative Security (Instr. 3)
Stock Option - Right to buy
2. Conversion or Exercise Price of Derivative Security
(i) $9.688 per share
(ii) $9.375 per share
3. Transaction Date (Month/Day/Year)
(i) 7/31/98
(ii) 4/9/99
4. Transaction Code (Instr. 8)
T
<PAGE>
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
(A) (D)
(i) 7,500 NA
(ii) 23,000
6. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable Expiration Date
(i) 7/31/00 7/31/08
(ii) 4/9/01 4/9/09
7. Title and Amount of Underlying Securities (Instr. 3 and 4)
Title Amount or Number of Shares
(i) 7/31/00 7,500
(ii) 4/9/01 23,000
8. Price of Derivative Security (Instr. 5)
NA
9. Number of Derivative Securities Beneficially Owned at End of Year
(Instr. 4)
Number of derivative securities acquired= 30,500
Other options previously reported = 0
Total owned at end of year 30,500
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
D
11. Nature of Indirect Beneficial Ownership (Instr. 4)
NA
Explanation of Responses:
NA
/s/ Patrick Waddy
Signature of Reporting Person
7/14/99
Date
